Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|November 11, 2017
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancerJordi Codony-Servat, Miriam Cuatrecasas, Elena Asensio, et al.
European Urology Oncology|March 1, 2024
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer PatientsNatalia Jiménez, Marta Garcia de Herreros, Òscar Reig, et al.
Journal of the National Cancer Institute|July 2, 2025
Stromal tumor infiltrating lymphocytes and TNBC-DX provide complementary prognostic information in triple-negative breast cancerShane R Stecklein, Miguel Martín, Guillermo Villacampa, et al.
Open Forum Infectious Diseases|October 2, 2020
Genotypic and Phenotypic Characteristics of Staphylococcus aureus Prosthetic Joint Infections: Insight on the Pathogenesis and Prognosis of a Multicenter Prospective CohortIrene Muñoz-Gallego, Esther Viedma, Jaime Esteban, et al.
Journal of the American College of Cardiology|November 24, 2024
A Contemporary Picture of Coagulase-Negative Staphylococcal Endocarditis: A Nationwide GAMES Cohort StudyClara Palom-Grau, Guillermo Cuervo, Patricia Muñoz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
Associations of the HER2DX Genomic Test with Biological and Pathological Features in HER2-positive Breast CancerEsther Sanfeliu, Anabel Martínez-Romero, Mercedes Marín-Aguilera, et al.
JAMA Oncology|April 27, 2023
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without PertuzumabCoralia Bueno-Muiño, Isabel Echavarría, Sara López-Tarruella, et al.
Nature Communications|March 1, 2023
Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancerAleix Prat, Fara Brasó-Maristany, Olga Martínez-Sáez, et al.
NPJ Breast Cancer|April 25, 2025
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumabRodrigo Sánchez-Bayona, Olga Martínez-Sáez, Denys Romero-Romero, et al.
Journal of Clinical Medicine|April 28, 2023
Evolution of Quality of Life and Treatment Adherence after One Year of Intermittent Bladder Catheterisation in Functional Urology Unit PatientsBlanca Fernandez-Lasquetty Blanc, Antonio Hernández Martínez, Carlos Lorenzo García, et al.
Pageof 16